Data coverage, completeness and provenance for VECTUS BIOSYSTEMS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T01:28:10. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0750 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0790 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0790 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0800 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0900 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/VBS/prices · Price parameters and adjustment semantics
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops a pipeline of antifibrotic assets targeting cardiovascular, renal and liver fibrosis to address diseases driven by pathological tissue scarring. Its lead compound is VB0004, currently under phase Ib clinical human trial, which targets the prevention and reversal of fibrosis in the lungs, heart, and kidneys. The company was incorporated in 2005 and is based in Rosebery, Australia.
Website: https://www.vectusbiosystems.com.au · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/VBS/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 23 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 26 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 27 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 25 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/VBS
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/VBS/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/VBS/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/VBS/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/VBS/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/VBS
Free tier — instant API key. Built for AI agents.